ArticleJournal of ovarian research2025
Kisspeptin mediates the impact of chronic psychological stress on reproductive and metabolic dysregulation in polycystic ovary syndrome: evidence from human and rat models.
Article in Journal of ovarian research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
Abstract
Polycystic ovary syndrome (PCOS) and mental health disorders have high rates of co-occurrence. Although the precise pathophysiological mechanisms remain unknown, the observed changes in those conditions may be modulated by kisspeptin (Kiss1), a protein that regulates energy metabolism.
aimThe aim of this study was to investigate whether Kiss1 plays an important role in linking dysfunctional reproductive processes and abnormalities in energy metabolism in PCOS, both in humans and using a rat model of PCOS combined with chronic unpredictable mind stress (CUMS).
methodsIn 27 women with PCOS and 11 controls, fasting insulin (INS), blood glucose, Kiss1, and monoamine neurotransmitter levels were measured. For the animal experiments, the 16 rats were divided into control, PCOS, CUMS, and PCOS + CUMS groups to assess changes in behaviour, reproductive endocrine function, glucose metabolism, and granulosa cell apoptosis, as well as alterations in the expression levels of Kiss1, Kiss1 receptor (Kiss1R), and gonadotropin-releasing hormone (GnRH) in hypothalamic tissues and changes in INS-like growth factor 1 (IGF-1) and IGF-binding protein 1 (IGFBP-1) levels in ovarian tissues.
resultsThe body mass index, fasting INS levels, homeostatic model assessment of insulin resistance (HOMA-IR) index, and serum Kiss1 levels were significantly elevated in women with PCOS compared to the values in the healthy controls, whereas serum monoamine neurotransmitters levels were lower. Kiss1 levels negatively correlated with monoamine neurotransmitter concentrations and positively correlated with both INS levels and the HOMA-IR index. In the PCOS+CUMS model rats, reproductive endocrine dysfunction, abnormal glucose metabolism, and depressive-like behaviours were observed; these changes were accompanied by upregulated expression of Kiss1 and gonadotropin-releasing hormone (GnRH), downregulated IGF-1 levels, and increased ovarian granulosa cell apoptosis.
conclusionsCUMS exposure reduces monoamine neurotransmitter levels in PCOS, weakening Kiss1’s inhibitory effects., while regulating ovarian IGF-1 expression may promote granulosa cell apoptosis and reduce INS sensitivity, aggravating reproductive endocrine disorders and abnormal glucose metabolism in patients with PCOS-related psychological stress.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.